This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sierra, M. L. M.
Right arrow Articles by Calero, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sierra, M. L. M.
Right arrow Articles by Calero, M. A.
Related Collections
Right arrow Infectious Disease & Immunity

PEDIATRICS Vol. 104 No. 2 August 1999, p. e24

ELECTRONIC ARTICLE:
Kikuchi's Disease With Multisystemic Involvement and Adverse Reaction to Drugs

Received Jul 27, 1998; accepted Mar 3, 1999.

Maria L. Murga Sierra*, Eva Vegas*, Javier E. Blanco-González*, Almudena GonzálezDagger , Pilar MartínezDagger , and Maria A. Calero§

From the Department of * Pediatrics, Dagger  Pathology, and § Hematology, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, Spain.

Kikuchi's disease (KD), or histiocytic necrotizing lymphadenitis, was initially described in Japan in 1972. In the following years, several series of cases involving patients of different ages, races, and geographic origins were reported, but pediatric reports have been rare.

The etiology of KD is unknown, although a viral or autoimmune hypothesis has been suggested. The most frequent clinical manifestation consists of local or generalized adenopathy, although in some cases, it is associated with more general symptoms, multiorganic involvement, and diverse analytic changes (leukopenia, elevated erythrocyte sedimentation rate, and C-reactive protein, as well as an increase of transaminases and serum lactic dehydrogenase).

Diagnosis is based on characteristic pathologic findings that permit differentiation of this disease from lymphoma, systemic lupus erythematosus, and infectious lymphadenopathies.

We present here the case of a 14-year-old boy who presented with severe systemic manifestations and transient fulminant hepatic failure in response to treatment with antituberculosis drugs. Kikuchi's disease, lymphadenitis, liver failure, antituberculosis drugs.

.




This article has been cited by other articles:


Home page
 LupusHome page
G F de Larranaga, G I Remondino, R R Forastiero, E R Cunto, M Narbaitz, A B Olenchuk, N S Zala, and J A S. Juan
Catastrophic antiphospholipid syndrome and Kikuchi-Fujimoto disease: the first case reported
Lupus, December 1, 2005; 14(12): 967 - 969.
[Abstract] [PDF]

Home page
 NeoReviewsHome page
M. A. Thomson
Early Nasal Continuous Positive Airway Pressure To Minimize The Need for Endotracheal Intubation and Ventilation
NeoReviews, April 1, 2005; 6(4): e184 - e188.
[Full Text] [PDF]